Sarcoma & GIST
Missing efficacy data from the pivotal ENLIVEN trial and adverse liver events were points of contention.
ATLANTA – A teenage girl with advanced osteosarcoma has had a durable complete remission after receiving CAR T cells targeted to HER2.
ATLANTA – Although HER2 expression in osteosarcoma and rhabomyosarcoma is too low for HER2-targeted therapies such...
From the Editor
SAN FRANCISCO – A one-two approach to stimulating both innate and adaptive immunity appears to be paying off, suggest early efficacy data from a...
From the Journals
There were no concerning immune-mediated toxicities or changes in HIV-related parameters observed among 73 patients with HIV infection who had...
The oral tyrosine kinase inhibitor was associated with durable responses and a high progression-free survival rate in patients with refractory or...